𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The clinical progression of Parkinson's disease

✍ Scribed by Werner Poewe; Philipp Mahlknecht

Book ID
117754033
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
314 KB
Volume
15
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The need for levodopa as an end point of
The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and Ξ±-tocopherol
✍ Dr. Peter LeWitt; David Oakes; Lu Cui πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 693 KB

## Abstract Progression of Parkinson's disease (PD) can be detected through changes in clinical ratings or disability assessments. A clinical trial, Deprenyl and Alpha‐Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP), used a novel study end point: increase in parkinsonian disability to th

Clinical measures of progression in Park
Clinical measures of progression in Parkinson's disease
✍ Werner Poewe πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 1 views

## Abstract Despite all recent advances in symptomatic therapy Parkinson's disease (PD) continues to be a relentlessly progressive neurodegenerative disorder. Therefore therapies that will slow or hold disease progression are a major medical unmet need in PD. Clinical measures of disease progressio